Preethi Sundaram

Insider Reports History

Entity
Individual
Location
355 Alhambra Circle, Suite 801, Coral Gables, FL
Signature
/s/ Preethi Sundaram
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Preethi Sundaram:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CATALYST PHARMACEUTICALS, INC. Chief Strategy Officer Restricted Stock Units 702K $15.9M $22.67 Dec 9, 2024 Direct
CATALYST PHARMACEUTICALS, INC. Chief Strategy Officer Common Stock, par value $0.001 per share 30K $680K $22.67 Dec 9, 2024 Direct
CATALYST PHARMACEUTICALS, INC. Chief Strategy Officer Options to purchase common stock 709K Nov 21, 2024 Direct
CATALYST PHARMACEUTICALS, INC. Chief Strategy Officer Options to purchase common stock 557K Dec 8, 2023 Direct

Insider Reports Filed by Preethi Sundaram

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CPRX CATALYST PHARMACEUTICALS, INC. Dec 9, 2024 3 $0 4 Dec 11, 2024 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Nov 21, 2024 2 $0 4 Nov 25, 2024 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Feb 15, 2024 3 $0 4 Feb 16, 2024 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Dec 27, 2023 3 $0 4 Dec 29, 2023 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Dec 8, 2023 2 $0 4 Dec 12, 2023 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Feb 15, 2023 3 $0 4 Feb 17, 2023 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Dec 27, 2022 2 $0 4 Dec 29, 2022 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Nov 11, 2022 4 -$618K 4 Nov 15, 2022 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Sep 15, 2022 3 -$164K 4 Sep 16, 2022 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Feb 14, 2022 1 $0 4 Feb 16, 2022 Chief Strategy Officer
CPRX CATALYST PHARMACEUTICALS, INC. Dec 28, 2021 1 $0 4 Dec 30, 2021 Chief Product Devel. Officer
CPRX CATALYST PHARMACEUTICALS, INC. Jul 6, 2021 0 $0 3 Jul 13, 2021 Chief Product Devel. Officer